
Release date: 2024-08-28 16:41:19 Article From: Lucius Laos Recommended: 235
Stiripentol is specifically used in the treatment of Dravet syndrome-related seizures by modulating GABA receptors and reducing the frequency of generalized clonic seizures. Clinical studies have shown that Stiripentol has become an important option for the treatment of this syndrome.
Stiripentol is now available in oral suspensions and capsules to meet the individual needs of different patients.
The specifications of oral suspension include 250mg*60 sachets and 500mg*60 sachets, and the prices are about 3,300 yuan and 6,000 yuan per box, respectively, providing patients with a variety of treatment options.
Another type of stitail capsules, which is portable and easy to take, is available in two sizes: 250mg*60 capsules and 500mg*60 capsules, with prices of about 2,800 yuan and 4,500 yuan per box, respectively, so that patients can choose the most suitable treatment plan according to their actual situation. Patients should also understand the efficacy of the drug in clinical trials before choosing a drug treatment.
The following is a review of the therapeutic effects of Stiripentol in two clinical trials:
In Experiment 1, Stiripentol demonstrated superior efficacy, significantly more than patients in the Placebo treatment group achieved a significant reduction in seizure frequency, a statistically significant difference.
In the second experiment, the sample size was smaller, but Stiripentol still showed a significant efficacy advantage, and more patients treated with Stiripentol achieved a significant reduction in seizure frequency compared to Placebo, and this difference in efficacy was statistically validated. The drug has achieved good efficacy in the experiment, and patients should also be concerned about potential adverse reactions during the medication.
As with other drugs, Stiripentol may have some potential adverse effects during the trial.
Drowsiness is characterized by people who feel unusually tired or sleepy during the day and may need more sleep time, affecting daily life and work. This symptom may cause discomfort during activity, difficulty concentrating, and affect the overall quality of life.
Decreased appetite makes patients feel a lack of interest in food, which can lead to reduced food intake and inadequate nutrient intake. Long-term loss of appetite can lead to weight loss and malnutrition, affecting the normal functioning and health status of the body.
Patients should pay attention to the adverse reactions in the process of medication, and report to the doctor for treatment in time if they are not well.
[Warm tips] When choosing a version of stiripentol, patients should consider several factors, including the reliability of the drug's source, price, dosage needs, and physician recommendations.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:672025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3662024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:602025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:792025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:742025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:942025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:902025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:932025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: